TÜBİTAK Project Support to Dr. Sibel SARI TÜRK

01 Ocak 2026

TÜBİTAK 1002 project titled "Investigation of the Cytotoxic and Apoptotic Effects of Combining Aurora Kinase B Inhibition with Chemotherapeutic Agents in Colorectal Cancer" has been approved under the leadership of our department member Dr. Sibel SARI TÜRK.